Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy
Background Immune-checkpoint inhibitors (ICIs) remain ineffective in a large group of non-small cell lung cancer (NSCLC) patients. Mucosal-associated invariant T (MAIT) cells, a population of unconventional innate-like T lymphocytes abundant in the human body, play important roles in human malignanc...
Saved in:
Main Authors: | Dongyan Shi, Lin Lin, Yun Chen, Jian Liu, Lin Shi, Jinying Lu, Da Zhong, Meijuan Song, Wenhua You, Wen-Hui Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/1/e005902.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MAIT cells protect against sterile lung injury
by: Xiawei Zhang, et al.
Published: (2025-02-01) -
Incidence of hematological toxicity with use of immunotherapy and chemotherapy in advanced non-small cell lung cancer
by: Wenhai Fu, et al.
Published: (2025-01-01) -
Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma
by: Zihao Sun, et al.
Published: (2025-01-01) -
Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer
by: Wencui Kong, et al.
Published: (2022-01-01) -
The Relationship of Sirtuin 1 and Sirtuin 2 Expression with Clinicopathological Parameters in Non Small-Cell Lung Carcinomas
by: Fatma Cakmak Kazanci, et al.
Published: (2024-11-01)